Ayurvedic enema in the treatment of Dyslipidemia

Comparative Study of Efficacy of Modified Mushkakadi Basti and Lekhan Basti in the Management of Dyslipidemia

Status

Recruiting

Phases

Phase 3Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/07/044232

Enrollment

Registered

2022-07-21

Start date

Unknown

Completion date

Unknown

Last updated

2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E789- Disorder of lipoprotein metabolism, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients who are willing to give written consent 2. Newly diagnosed dyslipidemia patient 3. Serum Cholesterol less than 239mg per dl 4. Serum Triglycerides less than 199mg per dl 5. Serum HDL less than 40mg per dl 6. Serum LDL less than 159mg per dl 7. Serum VLDL more than 50mg per dl 8. Patient with controlled hypertension systolic not more than 140mg per dl and diastolic not more than 90 mm per hg 9. Patient with controlled type II diabetes fasting below 130mg per dl PP below 180mg per dl 10. All or any of these

Exclusion criteria

Exclusion criteria: 1. Patients below 20 years and above 60 years 2. Patient not willing to give written consent 3. With other systemic diseases like cardiovascular diseases associated with any rectal pathology like Hemorrhoids Fissure etc 4. Patients not fit for niruh basti

Design outcomes

Primary

Measure	Time frame
To Assess the Efficacy of Modified Mushkakadi Basti in Lipid ProfileTimepoint: 8 days	—

Secondary

Measure	Time frame
To Assess the Efficacy of Lekhan Basti in Lipid ProfileTimepoint: 8 days	—

Countries

India

Contacts

Public ContactDr Vinod Ade

Datta Meghe Institute of Medical Sciences Wardha

sonurajwade.rajwade2@gmail.com8654954815

Outcome results